Results 61 to 70 of about 424,109 (164)

Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results

open access: yesFrontiers in Immunology, 2021
Background: BNT162b2 and mRNA-1273 are the two recently approved mRNA-based vaccines against COVID-19 which has shown excellent safety and efficacy. Preliminary data about specific and neutralizing antibodies is available covering the first 100 days ...
Andrea Lombardi   +13 more
doaj   +1 more source

Impact of COVID‐19 and Vaccination on Lower Urinary Tract Symptoms: Insights From a Prospective Cohort Study

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Aims To evaluate the prevalence, clinical course, and risk factors of lower urinary tract symptoms (LUTS) in patients hospitalized with COVID‐19, and to assess associations with comorbidities, disease severity, and vaccination status. Methods We conducted a prospective cohort study of adult patients hospitalized with confirmed COVID‐19, who ...
Julia Duarte de Souza   +12 more
wiley   +1 more source

DataSheet_1_Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters.pdf [PDF]

open access: yes
BackgroundCharacterizing the antibody epitope profiles of messenger RNA (mRNA)-based vaccines against SARS-CoV-2 can aid in elucidating the mechanisms underlying the antibody-mediated immune responses elicited by these vaccines.MethodsThis study ...
Michael Jhatro (18175222)   +17 more
core   +1 more source

Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia

open access: yesImmunity, Inflammation and Disease, 2023
Background and Objectives Since publishing successful clinical trial results of mRNA coronavirus disease 2019 (COVID‐19) vaccines in December 2020, multiple reports have arisen about cardiovascular complications following the mRNA vaccination. This study
Farah Yasmin   +12 more
doaj   +1 more source

IgG anti-RBD levels during 8-month follow-up post-vaccination with BNT162b2 and mRNA-1273 vaccines in healthcare workers: A one-center study

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
IntroductionSince the COVID-19 outbreak, specific mRNA-based anti-SARS-CoV-2 vaccines have been developed and distributed worldwide. Because this is the first time that mRNA vaccines have been used, there are several questions regarding their capacity to
Sergio Gil-Manso   +76 more
doaj   +1 more source

Machine Learning‐Guided Near‐Infrared Laser Processing for Precise Geometry Control in Microneedles with Downstream microLED‐Triggered Photothermal Functionality

open access: yesSmall, EarlyView.
Machine learning‐guided near‐infrared laser processing enables predictive fabrication of microneedles with application‐specific geometries. The optimized metal templates are translated into polymeric microneedles and integrated with a flexible microLED platform.
Ismail Eş   +4 more
wiley   +1 more source

Myocarditis after BNT162b2 and mRNA-1273 COVID-19 vaccination: A report of 7 cases [PDF]

open access: yes, 2022
This is a multi-center case series study. In this study, we present 7 patients diagnosed with myocarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination on March 7, 2021, and March 3 ...
Sirwan Khalid Ahmed
core   +1 more source

Risk of herpes zoster following mRNA COVID-19 vaccine administration

open access: yesExpert Review of Vaccines, 2023
Background Adverse events following mRNA COVID-19 vaccines, including herpes zoster (HZ), have been reported. We conducted a cohort study to evaluate the association between mRNA COVID-19 vaccination and subsequent HZ at Kaiser Permanente Southern ...
Ana Florea   +7 more
doaj   +1 more source

Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study

open access: yesVaccines, 2022
The currently authorized mRNA COVID-19 vaccines, Pfizer-BNT162b2 and Moderna-mRNA-1273, offer great promise for reducing the spread of the COVID-19 by generating protective immunity against SARS-CoV-2.
Farah M. Shurrab   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy